Skip to main content

Table 1 Demographic and clinical characteristics of the CF patients

From: Determinants of exercise capacity in cystic fibrosis patients with mild-to-moderate lung disease

∆F 508 homozygous mutationa 31/79 (40%)
Smokera 10/102 (10%)
Oxygen supplementationa 11/95 (11%)
ABPAa 33/95 (35%)
Exocrine pancreatic insufficiencya 78/102 (76%)
Diabetesa 21/102 (21%)
Nasal polyposisa 25/94 (27%)
BMI, kg/m2b 20 (20 ± 3)
Lean body mass, kgb 45 (48 ± 9)
Pseudomonas aeruginosa a 63/99 (63%)
Staphylococcus aureus MSa 36/99 (36%)
Mycobacterium abscessa 4/99 (4%)
Blood leukocytes, 1012/mm3b 9 (9.7 ± 3.8)
Blood polymorphonuclear neutrophils, 1012/mm3b 6 (6.4 ± 3.3)
CRP, mg/Lb 5.5 (15 ± 30)
Serum albumin, g/Lb 42 (42 ± 4)
  1. ABPA = allergic bronchopulmonary aspergillosis; BMI = body mass index; CRP = C-reactive protein.
  2. Qualitative variables are given as frequency and percentage.
  3. aResults are expressed as number (percentage) of patients.
  4. bResults are expressed as median values (mean ± SD).